AI-Enhanced Review for Cancer Treatment Safety

OM
VX
Overseen ByVictoria Xu
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: UNC Lineberger Comprehensive Cancer Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This prospective study will test artificial intelligence (AI) and machine learning (ML) decision support tools. This tool is designed to help doctors, physicists and other staff during pre-treatment peer review, a step where treatment plans are checked before a patient begins care.

The system highlights summaries showing how different providers may vary in their treatment planning (provider-variability summaries) and points out the best signals or warning signs to look for (optimal cues). By drawing attention to these patterns and cues, the tool aims to help reviewers spot possible treatment-planning mistakes earlier, reduce the chance of errors, and improve overall patient safety.

Who Is on the Research Team?

LM

Lukasz Mazur, PhD

Principal Investigator

UNC Lineberger Comprehensive Cancer Center

Are You a Good Fit for This Trial?

Inclusion Criteria

I am 18 or older and have had prostate cancer radiation at a participating site.
I am 18 or older and attend peer-review meetings at a participating clinic.

Exclusion Criteria

My healthcare team can follow all study procedures and requirements.
Has dementia, altered mental status, or any psychiatric or co-morbid condition prohibiting the understanding or rendering of informed consent

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Pre-treatment Peer Review

AI-enhanced peer review process to identify and correct potential errors in radiation therapy treatment plans before therapy begins

Baseline

Radiation Therapy

Patients receive radiation therapy with treatment plans reviewed and potentially adjusted based on AI-enhanced peer review

Varies per patient

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • AI-Enhanced Pretreatment Peer-review Process

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Active Control

Group I: ProvidersExperimental Treatment1 Intervention
Group II: PatientsActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

UNC Lineberger Comprehensive Cancer Center

Lead Sponsor

Trials
377
Recruited
95,900+

Agency for Healthcare Research and Quality (AHRQ)

Collaborator

Trials
415
Recruited
6,777,000+